13 – FDA 21 CFR Part 211 Records and Reports (S14E10)

This episode examines Subpart J of 21 CFR Part 211, which emphasizes the critical role of accurate, legible, and contemporaneously maintained records in pharmaceutical manufacturing. We discuss how comprehensive recordkeeping is fundamental for demonstrating compliance with Good Manufacturing Practice (GMP) requirements. The discussion covers everything from retention policies and audit trails to data security and the validation of electronic record-keeping systems. We also explore the transition from paper records to electronic systems.

The episode explains how comprehensive records support effective quality management, facilitate regulatory inspections, and serve as the basis for product release decisions and corrective action investigations. We highlight the importance of data integrity and the need for qualified personnel to manage and interpret the vast amount of data generated throughout the manufacturing process. The aim is to illustrate how recordkeeping is not just about paperwork, but about creating a transparent, traceable, and reliable system that underpins the entire pharmaceutical operation. It showcases accountability.